Recent Posts
- Illinois Attorney General Files Lawsuit Against HIV/AIDS Nonprofit
- California Gov. Arnold Schwarzenegger Signs Budget That Cuts $52M From HIV/AIDS Programs
- Efforts Underway In Namibia To Treat Pediatric HIV
- HIV/AIDS Education Project Targeting Pennsylvania Black Women Examined
- Also In Global Health News: Uganda Male Circumcision; Malaria Vaccine; Potential Global Fund Grant In Cambodia; PMTCT Of HIV In Botswana
Random Posts
- Financial Times To Launch Special Report On 'Combating AIDS' With Contribution To Global Business Coalition
- Houston Task Force To Target Hispanic Residents For HIV Testing
- New HIV Recommendations To Improve Health, Reduce Infections And Save Lives
- Review Of Brazil's HIV/AIDS Treatment Programs Shows Importance Of Generic Drugs, Researchers Say
- HIV/AIDS Research Efforts Of New York Scientist Featured
- GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
- 10th Functional Genomics: Chemical Biology 2009
- Global Monitoring System Will Tell Whether HIV-Reduction Goals For 2015 Will Be Met
- Washington, D.C., Church Addresses HIV Stigma, Teaches Safe Sex To Black, Gay Congregation
- New York Legislature Should Approve Legislation Requiring Health Workers To Offer HIV Testing, Editorial Says
Prescription AIDS Drugs
Contact Us
Yale Physicians Receive $4.1 Million Grant To Study New Treatment For Alcohol-Dependent HIV-Positive Inmates Transitioning Back Into Society
November 05th, 2009
Two Yale School of Medicine physicians have been awarded a $4.1 million research grant from the National Institutes of Health (NIH) to study a new pharmacological treatment for newly released HIV-positive inmates with alcohol dependence who are transitioning back into the community.
The U.S. prison population is disproportionately impacted by HIV and by alcohol and drug abuse. A majority of HIV-positive inmates also have substance abuse disorders. Though many are treated successfully for both HIV and substance abuse while incarcerated, they face enormous challenges when released.
“Released HIV-positive inmates who relapse to alcohol and drug use are less likely to adhere to HIV treatment, including antiretroviral drugs, and more likely to engage in high-risk behavior,” according to Frederick L. Altice, M.D., professor at Yale School of Medicine, director of clinical and community research at the Yale AIDS Program and one of the two principal investigators.
The prestigious NIH grant is the first of its stature for Sandra Springer, M.D., assistant professor of medicine and co-principal investigator - a junior investigator whose career has already benefited from a career development award from the NIH. In the clinical trial led by Springer and Altice, 125 HIV-positive prisoners with alcohol dependence who are transitioning back into society will receive subcutaneous (depot) injections of naltrexone. Though the medication has been previously shown to benefit those with alcohol dependence, HIV-infected individuals were never previously included in clinical trials.
All subjects in the trial, whether getting naltrexone or the placebo, will receive comprehensive case-management services and 24 weeks of counseling. “This is the first time that depot naltrexone will be formally tested in HIV-infected patients,” says Springer. She adds, “We hope to learn whether a medication known to benefit those with alcohol problems will also help assist with HIV treatment and prevent a relapse to high-risk behaviors. Our study could confirm that treating one disease, alcohol dependence, can actually fight two life-threatening conditions.”
Source
Yale University
View drug information on Naltrexone Hydrochloride Tablets.
Related posts:
- Video Game To Help Urban Teens Avoid HIV Infection Focus Of Nearly $4 Million Grant To Yale Creating a video game to help teens avoid sex, drugs...
- Yale And University Of Malaya Join Forces To Battle HIV In Prisons In the hope of stemming one of the biggest...
- Program Once Reserved For Alabama Inmates With HIV/AIDS Expanded To All Inmates Patient / Public: Health Professional: Article Opinions: ...
- More Than Four Million HIV-positive People Now Receiving Life-saving Treatment More than 4 million people in low- and middle-income countries...
- Outstanding Minority Physicians Receive Awards Dedicated To HIV Medicine Two promising young physicians have been awarded this year’s Minority...
Related posts brought to you by Yet Another Related Posts Plugin.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.